Sundar PichaiSundar Pichai earned $164M in 2023

Leslie Hudson, PhD, served as the CEO of Sarepta Therapeutics, Inc. from July 2008 until April 2010. With a PhD in Molecular Biology, he helped steer the company through key developments in biotechnology, particularly in RNA therapeutics aimed at genetic...

Quick Links
S

Leslie Hudson, PhD

Ex-CEO of Sarepta Therapeutics, Inc.

Education

PhD in Molecular Biology

Field of Expertise

Healthcare & Life Sciences - Biotechnology

Sector of Economy

Healthcare

Born

September 17, 1957 - 67 years ago

CEO of Sarepta Therapeutics, Inc. for

1 year 8 months (Jul 2008 - Apr 2010)

Previous Experience

CEO of AVI BioPharma, Inc.

Rivals

Competitors/colleagues of Leslie Hudson, PhD

Holdings

See how much did Leslie Hudson, PhD make over time.

During his time at Sarepta, Leslie Hudson held significant stock options, including grants for up to 600,000 shares in 2010. His wealth in company stock saw fluctuations during his tenure, highlighting an interesting rollercoaster as the company navigated through challenging...

Insider Trading

See recent insider trades of Leslie Hudson, PhD.

No insider trades found for this CEO.

Compensation History

See how much did Leslie Hudson, PhD make over time.

In 2010, Leslie Hudson's total compensation was $932,871. His base salary was $494,400, with no bonus due to his resignation in April. He had significant stock options granted, mostly unvested when he left. This compensation package was designed to attract and retain executives during a crucial time for the company, but Hudson's unexpected departure highlighted the risks associated with leadership roles in high-stakes industries. Prior to this, in 2009, Hudson received a total compensation of $1,141,869, which included a notable performance bonus tied closely to corporate achievements. Although his time with Sarepta was marked by both challenges and opportunities, Hudson's legacy in the biotech space reflects the constant evolution and risks involved in leadership.

Year

2010

Total Compensation

$932.87K

Salary

$494.40K

Board Justification

The compensation philosophy aims to attract and retain senior executive management, motivate performance towards defined goals, and align long-term interests with shareholders.

Bonus

$0.00

Board Justification

Dr. Hudson was ineligible for a 2010 performance bonus due to his resignation in April 2010.

Other

$438.47K

Board Justification

Other compensation includes temporary living expenses, financial services, and cash severance costs.

Restricted Stock

$0.00(0 common stock)

Board Justification

No stock grants were vested in 2010 as Dr. Hudson resigned in April 2010.

Performance Metrics

Dr. Hudson's performance metrics were tied to corporate objectives, but he was ineligible for bonuses due to resignation.

Other Sarepta Therapeutics, Inc. CEOs

Here are other CEOs of Sarepta Therapeutics, Inc.